182 related articles for article (PubMed ID: 1284868)
1. Common and different antigenic properties of the rabies virus glycoprotein of strains SAD-Vnukovo and Pitman-Moore.
Máciková I; Dedek L; Vrzal V; Kontseková E; Kontsek P; Ciampor F; Novák M
Acta Virol; 1992 Dec; 36(6):541-50. PubMed ID: 1284868
[TBL] [Abstract][Full Text] [Related]
2. Conformation-dependent accessibility of the linear epitopes located on the rabies virus glycoprotein.
Kontsekova E; Macikova I; Novak M; Dedek L; Vrzal V; Kontsek P
Viral Immunol; 1992; 5(3):213-20. PubMed ID: 1418319
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of rabies virus neutralization.
Flamand A; Raux H; Gaudin Y; Ruigrok RW
Virology; 1993 May; 194(1):302-13. PubMed ID: 7683158
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterization of human monoclonal antibodies to G5, a linear neutralization epitope on glycoprotein of rabies virus, by phage display technology.
Zhao XL; Yin J; Chen WQ; Jiang M; Yang G; Yang ZH
Microbiol Immunol; 2008 Feb; 52(2):89-93. PubMed ID: 18380806
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing.
Raux H; Coulon P; Lafay F; Flamand A
Virology; 1995 Jul; 210(2):400-8. PubMed ID: 7542418
[TBL] [Abstract][Full Text] [Related]
6. G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates.
Wang Y; Rowley KJ; Booth BJ; Sloan SE; Ambrosino DM; Babcock GJ
Antiviral Res; 2011 Aug; 91(2):187-94. PubMed ID: 21693135
[TBL] [Abstract][Full Text] [Related]
7. Peptide mimotopes of rabies virus glycoprotein with immunogenic activity.
Houimel M; Dellagi K
Vaccine; 2009 Jul; 27(34):4648-55. PubMed ID: 19520204
[TBL] [Abstract][Full Text] [Related]
8. [Antigenic determination of human anti-rabies vaccine against viral street strains common in the wild animal population in Poland].
Seroka D
Med Dosw Mikrobiol; 1994; 46(4):331-47. PubMed ID: 7541494
[TBL] [Abstract][Full Text] [Related]
9. Characterization of rabies virus strains used for vaccine production by means of monoclonal antibodies.
Sureau P; Rollin P; Lafon M
Dev Biol Stand; 1984; 57():227-31. PubMed ID: 6084613
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the antigenic structure of rabies virus glycoprotein by monoclonal antibodies.
Lafon M; Ideler J; Wunner WH
Dev Biol Stand; 1984; 57():219-25. PubMed ID: 6084612
[TBL] [Abstract][Full Text] [Related]
11. Identification of rabies virus mimotopes screened from a phage display peptide library with purified dog anti-rabies virus serum IgG.
Yang L; Cen J; Xue Q; Li J; Bi Y; Sun L; Liu W
Virus Res; 2013 Jun; 174(1-2):47-51. PubMed ID: 23499997
[TBL] [Abstract][Full Text] [Related]
12. Novel monoclonal antibodies that bind to wild and fixed rabies virus strains.
Zanluca C; Aires LR; Mueller PP; Santos VV; Carrieri ML; Pinto AR; Zanetti CR
J Virol Methods; 2011 Jul; 175(1):66-73. PubMed ID: 21536074
[TBL] [Abstract][Full Text] [Related]
13. The reactions of monoclonal antibodies with structural proteins of mumps virus.
Orvell C
J Immunol; 1984 May; 132(5):2622-9. PubMed ID: 6201553
[TBL] [Abstract][Full Text] [Related]
14. Rabies virus-specific human T cell clones provide help for an in vitro antibody response against neutralizing antibody-inducing determinants of the viral glycoprotein.
Bunschoten H; Klapmuts RJ; Claassen IJ; Reyneveld SD; Osterhaus AD; Uytdehaag FG
J Gen Virol; 1989 Jun; 70 ( Pt 6)():1513-21. PubMed ID: 2471814
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein.
Bunschoten H; Gore M; Claassen IJ; Uytdehaag FG; Dietzschold B; Wunner WH; Osterhaus AD
J Gen Virol; 1989 Feb; 70 ( Pt 2)():291-8. PubMed ID: 2471786
[TBL] [Abstract][Full Text] [Related]
16. Mapping and characterization of a sequential epitope on the rabies virus glycoprotein which is recognized by a neutralizing monoclonal antibody, RG719.
Ni Y; Tominaga Y; Honda Y; Morimoto K; Sakamoto S; Kawai A
Microbiol Immunol; 1995; 39(9):693-702. PubMed ID: 8577283
[TBL] [Abstract][Full Text] [Related]
17. Partial antigenic characterization of potato virus S (Andean strain) by monoclonal antibodies.
Cerovská N; Filigarová M; Subr Z
Acta Virol; 1996 Feb; 40(1):23-6. PubMed ID: 8886094
[TBL] [Abstract][Full Text] [Related]
18. Antigenic analysis of rabies and Mokola virus from Zimbabwe using monoclonal antibodies.
Wiktor TJ; Macfarlan RI; Foggin CM; Koprowski H
Dev Biol Stand; 1984; 57():199-211. PubMed ID: 6526138
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies against avian reticuloendotheliosis virus: identification of strain-specific and strain-common epitopes.
Cui ZZ; Lee LF; Silva RF; Witter RL
J Immunol; 1986 Jun; 136(11):4237-42. PubMed ID: 2422277
[TBL] [Abstract][Full Text] [Related]
20. Competitive ELISA using a rabies glycoprotein-transformed cell line to semi-quantify rabies neutralizing-related antibodies in dogs.
Zhang S; Liu Y; Zhang F; Hu R
Vaccine; 2009 Mar; 27(15):2108-13. PubMed ID: 19356613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
